| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |